NCT03974620

Brief Summary

This study aims to test the hypothesis that addition of Individual Placement and Support (IPS) and/or Cognitive Remediation Therapy (CRT) in addition to treatment as usual in patients with early psychosis will be feasible and acceptable in patients with early schizophrenia.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P75+ for not_applicable schizophrenia

Timeline
Completed

Started Dec 2024

Shorter than P25 for not_applicable schizophrenia

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 18, 2019

Completed
18 days until next milestone

First Posted

Study publicly available on registry

June 5, 2019

Completed
5.5 years until next milestone

Study Start

First participant enrolled

December 1, 2024

Completed
29 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2024

Completed
Last Updated

May 17, 2024

Status Verified

May 1, 2024

Enrollment Period

29 days

First QC Date

May 18, 2019

Last Update Submit

May 16, 2024

Conditions

Outcome Measures

Primary Outcomes (3)

  • Feasibility of undertaking a trial of the intervention, as determined by: Recruitment and attrition rates

    Recruitment and attrition rates: This will be determined using recruitment and attrition rates into the trial

    6 month post intervention

  • Acceptability of the intervention, as determined by: number of sessions attended

    Therapy logs: therapy logs with number of sessions attended

    6 months post intervention

  • Client Satisfaction Questionnaire (CSQ)

    Participants' satisfaction will be measured using CSQ-8. The scale consists of 8 items score range from 8 to 32, with higher values indicating higher satisfaction.

    6 month post intervention

Study Arms (4)

Individual Placement and Support (IPS)

EXPERIMENTAL

IPS is a vocational support program to facilitate return to employment in individuals with severe and enduring mental illnesses.

Behavioral: Individual Placement and Support

Cognitive Remediation Therapy (CRT)

EXPERIMENTAL

CRT will be delivered twice weekly individual computerised CRT with therapist input. This therapy will be delivered by a CRT trained assistant psychologist.

Behavioral: Cognitive Remediation Therapy

IPS and CRT

EXPERIMENTAL

A combination of IPS and CRT will be provided to participants in this arm.

Behavioral: Individual Placement and SupportBehavioral: Cognitive Remediation Therapy

Treatment as usual

NO INTERVENTION

Continued input as normal with treating psychiatrist.

Interventions

Individual Placement and Support is a vocational support program that was developed in the USA, to facilitate return to employment in individuals with severe and enduring mental illnesses.

IPS and CRTIndividual Placement and Support (IPS)

This is an evidence based intervention that aims to improve cognitive functioning.

Cognitive Remediation Therapy (CRT)IPS and CRT

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Male/Female patients aged between 18-35 years.
  • Diagnosis of schizophrenia confirmed by SCID meeting DSM-V criteria for schizophrenia, schizophreniform or schizoaffective psychosis.
  • Stable on medication for the past four weeks.
  • In contact with mental health services
  • Within 5 years of diagnosis.
  • Able to demonstrate the capacity to provide informed consent to take part in this feasibility trial, as assessed by their own clinician.

You may not qualify if:

  • Active DSM-V substance abuse (except nicotine or caffeine) or dependence within the last three months
  • Relevant CNS or other medical disorders
  • Diagnosis of Learning Disability.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

SchizophreniaPsychotic Disorders

Interventions

Palliative Care

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Patient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 18, 2019

First Posted

June 5, 2019

Study Start

December 1, 2024

Primary Completion

December 30, 2024

Study Completion

December 30, 2024

Last Updated

May 17, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Anonymised data once analysed and published will be available on reasonable request.